Vaccine for Ebola virus

One of the world’s deadliest diseases, caused by the Ebola virus, may finally be preventable thanks to US and Canadian researchers, who have successfully tested several Ebola vaccines in primates and are now looking to adapt them for human use.

Dr Anthony Sanchez, from the Centers for Disease Control & Prevention in Atlanta, Georgia is presenting an overview of Ebola vaccine development today (Monday 31 March 2008) at the Society for General Microbiology’s 162nd meeting being held this week at the Edinburgh International Conference Centre.

“The biothreat posed by Ebola virus cannot be overlooked. We are seeing more and more naturally occurring human outbreaks of this deadly disease. With worldwide air travel and tourism the virus can now be transported to and from remote regions of the world. And it has huge potential as a possible weapon of bioterrorism”, says Dr Sanchez. “We desperately need a protective vaccine”.

So far, there have been over 1500 cases of Ebola haemorrhagic fever in humans. Illness starts abruptly and symptoms include fever, headache, sore throat, weakness, joint and muscle aches, diarrhoea, vomiting and stomach pain. A rash, red eyes and bleeding may also occur. Ebola haemorrhagic fever can have a mortality rate of around 90% in humans.

Because Ebola virus is so dangerous, producing and testing a vaccine is extremely challenging for the scientists. One significant factor slowing down progress has been that there are only a very limited number of high containment facilities with staff capable and authorised to conduct the research.

“Ebola virus is a Biosafety Level 4 threat, along with many other haemorrhagic fever viruses”, says Dr Sanchez. “As well as the difficulty in getting the right staff and facilities, vaccines for viruses like Ebola, Marburg and Lassa fever have been difficult to produce because simple ‘killed’ viruses that just trigger an antibody response from the blood are not effective. For these viruses we need to get a cell-mediated response, which involves our bodies producing killer T-cells before immunity is strong enough to prevent or clear an infection.”

The researchers have now used several different recombinant DNA techniques, which have allowed them to trigger a cell-mediated response and produce a vaccine that is effective in non-human primates. One of the candidate vaccines is about to be tested on people for the first time, after entering Phase 1 clinical trials in autumn 2006.

“Ebola virus infection of humans can be highly lethal but monkeys rarely survive the infection and have been very useful as animal models. Ebola vaccine trials using nonhuman primates have provided unambiguous results and have allowed the development of protective vaccines to progress rapidly”, says Dr Sanchez. “Successful human trials will mean that we can vaccinate healthcare workers and other key personnel during outbreaks of Ebola haemorrhagic fever, helping us to protect their lives and control the spread of the disease”.

The US team hopes that the findings from their studies will provide important insights that will improve or accelerate the future development of vaccines for other haemorrhagic fever viruses like Marburg virus, and agents such as HIV and avian influenza.

Source: Society for General Microbiology

Related stories:

Scientists uncover Ebola cell-invasion strategy
University of Texas Medical Branch at Galveston researchers have discovered a key biochemical link in the process by which the Ebola Zaire virus infects cells — a critical step to finding a way to treat the deadly disease produced by the virus.
Scientists reveal key structure from ebola virus
Described in the July 10, 2008 issue of the journal Nature, the research reveals the shape of the Ebola virus spike protein, which is necessary for viral entry into human cells, bound to an immune system antibody acting to neutralize the virus. The structure provides a major step forward in understanding how the deadly virus works, and may be useful in the development of potential Ebola virus vaccines, or treatments for those infected.
Study garners unique mating photos of wild gorillas
Scientists from the Wildlife Conservation Society and Max Planck Institute for Evolutionary Anthropology have released the first known photographs of gorillas performing face-to-face copulation in the wild. This is the first time that western gorillas have been observed and photographed mating in such a manner.
Ebola virus disarmed by excising a single gene
The deadly Ebola virus, an emerging public health concern in Africa and a potential biological weapon, ranks among the most feared of exotic pathogens.
New genetic lineage of Ebola virus discovered in great apes
Since its discovery 30 years ago, Ebolavirus has struck repeatedly in several epidemics breaking out mainly in Central Africa. Gorillas and chimpanzees are also victims of the violent haemorrhagic fever attacks the virus triggers. With the aim of understanding more of Ebola’s action mechanisms, scientists collect viral RNA samples from infected individuals at each outbreak. Hitherto it was only possible to analyse genetic sequences isolated from humans.
NASA technology helps predict and prevent future pandemic outbreaks
With the help of 14 satellites currently in orbit and the National Aeronautics and Space Administration's (NASA) Applied Sciences Program, scientists have been able to observe the Earth’s environment to help predict and prevent infectious disease outbreaks around the world. The use of remote sensing technology aids specialists in predicting the outbreak of some of the most common and deadly infectious diseases today such as Ebola, West Nile virus and Rift Valley Fever.
The reservoir of Marburg virus identified in a species of fruit bat
The Marburg virus, like its fearsome cousin Ebola, belongs to the Filoviridae family. It carries the name of the German town where it was first detected in 1967, after a mysterious epidemic had hit employees of the Behring laboratory.
Discovery may help defang viruses
Researchers may be able to tinker with a single amino acid of an enzyme that helps viruses multiply to render them harmless, according to molecular biologists who say the discovery could pave the way for a fast and cheap method of making vaccines.

News discussion:

Medicine & Health news